Obesity

Association of body mass index and long-term mortality in patients from nationwide LIPIDOGRAM 2004–2015 cohort studies: no obesity paradox?

Cardiovasc DiabetolPublished Cohort study

Authors' conclusion

Being underweight, overweight or obese is associated with a higher mortality risk in a population of patients in primary care. Patients who lost weight were older and more burdened with cardiometabolic diseases, which may suggest unintentional weight loss, and were at higher risk of death in the long-term follow-up. In nonsmoking patients without comorbidities, the lowest mortality was observed in those with a BMI < 25 kg/m2, and no U-curve relationship was observed.

Study context

Population
Adults under the care of family physicians in primary care in Poland (LIPIDOGRAM 2004, 2006, 2015); 61.7% females44,620 with follow-up
Participants
45,615 participants
Exposure
Body mass index (BMI) categories vs normal weight
  • Normal weightn = 10,987reference
  • Underweightn = 320
  • Overweightn = 19,134
  • Obesityn = 15,174
Outcome
Long-term all-cause mortality
Follow-up
Up to December 2021; median 15.3 years
Methodological detailsnationwide, primary care, Kaplan-Meier and Cox regression analyses
  • Nationwide
  • Primary care
  • Kaplan-Meier and Cox regression analyses

Main finding

As reported in the abstract

All-cause mortality · median 15.3 years

Normal weight

14%

Adjusted for comorbidities
Each group vs normal weightHazard ratio (95% CI)
Class III obesity
1.79(1.55–2.05)
Underweight
1.57(1.22–2.04)

Observational data: associations, not effects.

Further findings

Weight decrease by 5% over 2 years (LIPIDOGRAM Plus, n=1627) and long-term mortality

HR for death
1.45 (95% CI 1.05-2.02, p = 0.03)

Weight decrease by 10% over 2 years (LIPIDOGRAM Plus) and long-term mortality

HR for death
1.67 (95% CI 1.02-2.74, p < 0.001)
Patients with weight loss were older and more burdened with comorbidities

Original publication

Association of body mass index and long-term mortality in patients from nationwide LIPIDOGRAM 2004–2015 cohort studies: no obesity paradox? Cardiovasc Diabetol. Published 28 November 2023. doi:10.1186/s12933-023-02059-0

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.